
Oxylabs Pharma Private Limited
Founded in 2013 and headquartered in Delhi, India.
Founded in 2013 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U24100DL2013PTC259857
259857
Private Limited Indian Non-Government Company
04 Nov 2013
30 Sep 2016
31 Mar 2016
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Subodh Kumar ![]() | Director | 04-Nov-2013 | Current |
Suchita Kumari ![]() | Director | 04-Nov-2013 | Current |
Enhance accessibility to Oxylabs Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2016, Oxylabs Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Suchita Kumari is a mutual person
Suchita Kumari is a mutual person
Suchita Kumari is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Oxylabs Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oxylabs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxylabs Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Oxylabs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.
Oxylabs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi.
Subodh Kumar was appointed as a Director was appointed as a Director on 04 Nov 2013 & has been associated with this company since 11 years 6 months .
Suchita Kumari was appointed as a Director was appointed as a Director on 04 Nov 2013 & has been associated with this company since 11 years 6 months .
Oxylabs Pharma Private Limited was registered on 04 Nov 2013 with Roc Delhi & aged 11 years 6 months as per MCA records.
Oxylabs Pharma Private Limited was incorporated on 04 Nov 2013.
The authorized share capital of Oxylabs Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Oxylabs Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Oxylabs Pharma Private Limited is House No 168 Landmark Sfs Flats Dr Mukherjee Nagar India, New Delhi, 110009.
The corporate identification number (CIN) of Oxylabs Pharma Private Limited is U24100DL2013PTC259857 and the company number is 259857 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Oxylabs Pharma Private Limited was filed with the ROC on 31 Mar 2016.
Search company & director profiles for free and gain access to critical business data.